- call +1-201-465-4211
- email sales@mrinsights.biz
The prostate is a walnut-sized gland located behind the base of a man’s penis, in front of the rectum, and below the bladder. Cancer begins when healthy cells in the prostate change and grow out of control, forming a tumor. A tumor can be cancerous or benign. A cancerous tumor is malignant, meaning it can grow and spread to other parts of the body. A benign tumor means the tumor can grow but will not spread.
Scope of the Report:
The classification of Prostate Cancer Diagnostics includes Tumor Biomarker Tests, Imaging, Biopsy and other, and most of Prostate Cancer Diagnostics use the method of Biopsy, the proportion of Biopsy in 2017 is about 44.65%.
Prostate Cancer Diagnostics is widely used for the people with Prostate Cancer, The most proportion of Prostate Cancer Diagnostics is used for people with the age between 55 and 75, and the proportion is about 70.24% in 2017.
North America region is the largest region of Prostate Cancer Diagnostics, with a revenue market share nearly 49.84% in 2017. Europe is the second region of Prostate Cancer Diagnostics, enjoying revenue market share nearly 28% in 2017.
The worldwide market for Prostate Cancer Diagnostics is expected to grow at a CAGR of roughly 7.9% over the next five years, will reach 15800 million US$ in 2024, from 10000 million US$ in 2019, according to a new study.
This report focuses on the Prostate Cancer Diagnostics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Genomic Health
Abbott
OPKO
Siemens Healthcare
DiaSorin
BioMeriux
Roche
MDx Health
Beckman Coulter
Myriad Genetics
Ambry Genetics
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Tumor Biomarker Tests
Imaging
Biopsy
Other
Market Segment by Applications, can be divided into
age < 55
age 55-75
age > 75
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Prostate Cancer Diagnostics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Prostate Cancer Diagnostics, with price, sales, revenue and global market share of Prostate Cancer Diagnostics in 2017 and 2018.
Chapter 3, the Prostate Cancer Diagnostics competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Prostate Cancer Diagnostics breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Prostate Cancer Diagnostics market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Prostate Cancer Diagnostics sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Prostate Cancer Diagnostics Introduction
1.2 Market Analysis by Type
1.2.1 Tumor Biomarker Tests
1.2.2 Imaging
1.2.3 Biopsy
1.2.4 Other
1.3 Market Analysis by Applications
1.3.1 age < 55
1.3.2 age 55-75
1.3.3 age > 75
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Genomic Health
2.1.1 Business Overview
2.1.2 Prostate Cancer Diagnostics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Genomic Health Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Abbott
2.2.1 Business Overview
2.2.2 Prostate Cancer Diagnostics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Abbott Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 OPKO
2.3.1 Business Overview
2.3.2 Prostate Cancer Diagnostics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 OPKO Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Siemens Healthcare
2.4.1 Business Overview
2.4.2 Prostate Cancer Diagnostics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Siemens Healthcare Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 DiaSorin
2.5.1 Business Overview
2.5.2 Prostate Cancer Diagnostics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 DiaSorin Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 BioMeriux
2.6.1 Business Overview
2.6.2 Prostate Cancer Diagnostics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 BioMeriux Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Roche
2.7.1 Business Overview
2.7.2 Prostate Cancer Diagnostics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Roche Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 MDx Health
2.8.1 Business Overview
2.8.2 Prostate Cancer Diagnostics Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 MDx Health Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Beckman Coulter
2.9.1 Business Overview
2.9.2 Prostate Cancer Diagnostics Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Beckman Coulter Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Myriad Genetics
2.10.1 Business Overview
2.10.2 Prostate Cancer Diagnostics Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Myriad Genetics Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.11 Ambry Genetics
2.11.1 Business Overview
2.11.2 Prostate Cancer Diagnostics Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Ambry Genetics Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Prostate Cancer Diagnostics Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Prostate Cancer Diagnostics Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Prostate Cancer Diagnostics Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Prostate Cancer Diagnostics Manufacturer Market Share in 2018
3.3.2 Top 6 Prostate Cancer Diagnostics Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Prostate Cancer Diagnostics Market Analysis by Regions
4.1 Global Prostate Cancer Diagnostics Sales, Revenue and Market Share by Regions
4.1.1 Global Prostate Cancer Diagnostics Sales and Market Share by Regions (2014-2019)
4.1.2 Global Prostate Cancer Diagnostics Revenue and Market Share by Regions (2014-2019)
4.2 North America Prostate Cancer Diagnostics Sales and Growth Rate (2014-2019)
4.3 Europe Prostate Cancer Diagnostics Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Prostate Cancer Diagnostics Sales and Growth Rate (2014-2019)
4.5 South America Prostate Cancer Diagnostics Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Prostate Cancer Diagnostics Sales and Growth Rate (2014-2019)
5 North America Prostate Cancer Diagnostics by Country
5.1 North America Prostate Cancer Diagnostics Sales, Revenue and Market Share by Country
5.1.1 North America Prostate Cancer Diagnostics Sales and Market Share by Country (2014-2019)
5.1.2 North America Prostate Cancer Diagnostics Revenue and Market Share by Country (2014-2019)
5.2 United States Prostate Cancer Diagnostics Sales and Growth Rate (2014-2019)
5.3 Canada Prostate Cancer Diagnostics Sales and Growth Rate (2014-2019)
5.4 Mexico Prostate Cancer Diagnostics Sales and Growth Rate (2014-2019)
6 Europe Prostate Cancer Diagnostics by Country
6.1 Europe Prostate Cancer Diagnostics Sales, Revenue and Market Share by Country
6.1.1 Europe Prostate Cancer Diagnostics Sales and Market Share by Country (2014-2019)
6.1.2 Europe Prostate Cancer Diagnostics Revenue and Market Share by Country (2014-2019)
6.2 Germany Prostate Cancer Diagnostics Sales and Growth Rate (2014-2019)
6.3 UK Prostate Cancer Diagnostics Sales and Growth Rate (2014-2019)
6.4 France Prostate Cancer Diagnostics Sales and Growth Rate (2014-2019)
6.5 Russia Prostate Cancer Diagnostics Sales and Growth Rate (2014-2019)
6.6 Italy Prostate Cancer Diagnostics Sales and Growth Rate (2014-2019)
7 Asia-Pacific Prostate Cancer Diagnostics by Country
7.1 Asia-Pacific Prostate Cancer Diagnostics Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Prostate Cancer Diagnostics Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Prostate Cancer Diagnostics Revenue and Market Share by Country (2014-2019)
7.2 China Prostate Cancer Diagnostics Sales and Growth Rate (2014-2019)
7.3 Japan Prostate Cancer Diagnostics Sales and Growth Rate (2014-2019)
7.4 Korea Prostate Cancer Diagnostics Sales and Growth Rate (2014-2019)
7.5 India Prostate Cancer Diagnostics Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Prostate Cancer Diagnostics Sales and Growth Rate (2014-2019)
8 South America Prostate Cancer Diagnostics by Country
8.1 South America Prostate Cancer Diagnostics Sales, Revenue and Market Share by Country
8.1.1 South America Prostate Cancer Diagnostics Sales and Market Share by Country (2014-2019)
8.1.2 South America Prostate Cancer Diagnostics Revenue and Market Share by Country (2014-2019)
8.2 Brazil Prostate Cancer Diagnostics Sales and Growth Rate (2014-2019)
8.3 Argentina Prostate Cancer Diagnostics Sales and Growth Rate (2014-2019)
8.4 Colombia Prostate Cancer Diagnostics Sales and Growth Rate (2014-2019)
9 Middle East and Africa Prostate Cancer Diagnostics by Countries
9.1 Middle East and Africa Prostate Cancer Diagnostics Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Prostate Cancer Diagnostics Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Prostate Cancer Diagnostics Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Prostate Cancer Diagnostics Sales and Growth Rate (2014-2019)
9.3 Turkey Prostate Cancer Diagnostics Sales and Growth Rate (2014-2019)
9.4 Egypt Prostate Cancer Diagnostics Sales and Growth Rate (2014-2019)
9.5 Nigeria Prostate Cancer Diagnostics Sales and Growth Rate (2014-2019)
9.6 South Africa Prostate Cancer Diagnostics Sales and Growth Rate (2014-2019)
10 Global Prostate Cancer Diagnostics Market Segment by Type
10.1 Global Prostate Cancer Diagnostics Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Prostate Cancer Diagnostics Sales and Market Share by Type (2014-2019)
10.1.2 Global Prostate Cancer Diagnostics Revenue and Market Share by Type (2014-2019)
10.2 Tumor Biomarker Tests Sales Growth and Price
10.2.1 Global Tumor Biomarker Tests Sales Growth (2014-2019)
10.2.2 Global Tumor Biomarker Tests Price (2014-2019)
10.3 Imaging Sales Growth and Price
10.3.1 Global Imaging Sales Growth (2014-2019)
10.3.2 Global Imaging Price (2014-2019)
10.4 Biopsy Sales Growth and Price
10.4.1 Global Biopsy Sales Growth (2014-2019)
10.4.2 Global Biopsy Price (2014-2019)
10.5 Other Sales Growth and Price
10.5.1 Global Other Sales Growth (2014-2019)
10.5.2 Global Other Price (2014-2019)
11 Global Prostate Cancer Diagnostics Market Segment by Application
11.1 Global Prostate Cancer Diagnostics Sales Market Share by Application (2014-2019)
11.2 age < 55 Sales Growth (2014-2019)
11.3 age 55-75 Sales Growth (2014-2019)
11.4 age > 75 Sales Growth (2014-2019)
12 Prostate Cancer Diagnostics Market Forecast (2019-2024)
12.1 Global Prostate Cancer Diagnostics Sales, Revenue and Growth Rate (2019-2024)
12.2 Prostate Cancer Diagnostics Market Forecast by Regions (2019-2024)
12.2.1 North America Prostate Cancer Diagnostics Market Forecast (2019-2024)
12.2.2 Europe Prostate Cancer Diagnostics Market Forecast (2019-2024)
12.2.3 Asia-Pacific Prostate Cancer Diagnostics Market Forecast (2019-2024)
12.2.4 South America Prostate Cancer Diagnostics Market Forecast (2019-2024)
12.2.5 Middle East and Africa Prostate Cancer Diagnostics Market Forecast (2019-2024)
12.3 Prostate Cancer Diagnostics Market Forecast by Type (2019-2024)
12.3.1 Global Prostate Cancer Diagnostics Sales Forecast by Type (2019-2024)
12.3.2 Global Prostate Cancer Diagnostics Market Share Forecast by Type (2019-2024)
12.4 Prostate Cancer Diagnostics Market Forecast by Application (2019-2024)
12.4.1 Global Prostate Cancer Diagnostics Sales Forecast by Application (2019-2024)
12.4.2 Global Prostate Cancer Diagnostics Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Prostate Cancer Diagnostics Picture
Table Product Specifications of Prostate Cancer Diagnostics
Figure Global Sales Market Share of Prostate Cancer Diagnostics by Ty
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
